EP-1644: Fast, high quality, semi-automated and fully-automated prostate radiotherapy treatment planning  by Wheeler, P.A. et al.
S768                                                                                                                                                  ESTRO 35 2016 
_____________________________________________________________________________________________________ 
linked to a virtual RA plan into the Eclipse TPS. Two full arcs 
with photon beam energies of 6MV and 30°/330° 
complementary collimator angle were set.. Two evaluation 
groups, consisting of 5 new knowledge based plans (KBP) 
each, were used to validate LR and IR models. KBP were 
compared with clinical plans (CP) in term of PTVs 
homogeneity, using HI = 100X (D2% - D98%)/D50%, and DVH 
endpoints, as shown in table 1. 
 
Results: The KBP dose-volume constraints, generated by HT 
based models, were suitable for the RA optimization process 
. The 2 models were effective to suggest optimization 
objectives consistent with the criteria set by an expert RA 
planner. The quantitative comparison analysis between CP 
and KBP over the entire cohort of patients was summarized in 
Table 1. These preliminary results, do not evidence any 
substantial differences between the benchmark and the test 
plans. 
 
 
 
 
 
Conclusion: RP, commonly used with models based on the 
same technique of the KBP plans (IMRT/VMAT), is able to 
create models trained using HT dose distributions to generate 
comparable RA plans, comparable to CP. The study was 
carried out for prostate cancer patients. 
 
EP-1644  
Fast, high quality, semi-automated and fully-automated 
prostate radiotherapy treatment planning 
P.A. Wheeler
1Velindre Cancer Centre, Medical Physics, Cardiff, United 
Kingdom 
1, M. Chu1, O. Woodley1, A. Paton2, R. Maggs1, 
D.G. Lewis1, J. Staffurth3, E. Spezi1, A.E. Millin1 
2Bristol Haematology and Oncology Centre, Radiotherapy 
Physics Unit, Bristol, United Kingdom 
3Cardiff University, School of Medicine, Cardiff, United 
Kingdom 
 
Purpose or Objective: Automated IMRT planning has been 
successfully developed for many treatment sites including 
prostate, lung, breast and head & neck. Evaluative studies 
have shown automated planning is clinically feasible, yields 
high quality treatment plans and improves efficiency. Clinical 
implementation is however slow due to the lack of available 
automated solutions or comprehensive scripting facilities 
within many treatment planning systems. This work addresses 
this shortfall through the application of prostate VMAT class 
solutions to implement fully automated planning in 
commercially available scriptable systems and semi-
automated planning in non-scriptable systems. 
 
Material and Methods: Class solutions for use with Raysearch 
Laboratories’ VMAT optimiser have been developed for 
prostate & seminal vesicles (Psv) and prostate, seminal 
vesicles & pelvic node (PPN) treatment sites. These solutions 
use novel optimisation methodologies to generate high 
quality, patient individualised plans in a single iteration 
round and require no decision making from an operator. 
These approaches were applied within Oncentra Master Plan 
v4.3 (OMP) and Raystation v4.6 to create semi-automated 
(OMP(SA)) and fully automated (RAY(FA)) treatment planning 
solutions respectively.  
10 Psv and 10 PPN patients were planned using both OMP(SA) 
and RAY(FA) plan generation techniques. For 5 Psv patients 
an experienced IMRT planner aimed to manually improve 
upon the OMP(SA) results to generate the ‘ideal’ treatment 
plan (OMP(Ideal)). Furthermore these 5 patients were 
planned by an external centre with limited VMAT experience 
to assess if the semi-automated solution could improve their 
working practices (OMP(External)). Plan quality was assessed 
using DVH metrics specified by the PIVOTAL trial and, with 
the exception of PPN OMP(SA), total planning time was 
recorded for each technique. 
 
Results: 
 
 
 
 
 
 
49/50 treatment plans assessed in the study passed PIVOTAL 
trial constraints, with OMP(External) failing on PTV coverage 
for one patient. Upon review RAY(FA), OMP(SA) and 
OMP(Ideal) were considered of comparable quality across all 
metrics and offered improved rectal sparing when compared 
OMP(External). For Psv treatments the mean planning time (± 
SD) was 10.3±1.4, 65.2±13.5, 229.0±35.8 and 255.2±48.0 
minutes for RAY(FA), OMP(SA), OMP(External) & OMP(Ideal) 
respectively. Average planning time for PPN RAY(FA) was 
38.2 ± 5.4 minutes. 
 
Conclusion: Semi-automated and fully automated planning 
yield high quality plans with significantly improved 
efficiency. 
 
 
 
